Baird Financial Group, Inc. Uni Qure N.V. Transaction History

Baird Financial Group, Inc.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 13, 2021	SELL	$29.24 - $42.03 $203,334 - $292,276	-6,954 Closed	0 $0
Q4 2020 Feb 11, 2021	SELL	$35.35 - $50.67 $23,401 - $33,543	-662 Reduced 8.69%	6,954 $251,000
Q3 2020 Nov 12, 2020	BUY	$35.98 - $47.66 $274,023 - $362,978	7,616 New	7,616 $280,000

142

35.3M

1.54M

389K

Ticker QURE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,729,100
Market Cap $300M
Description
uniQure N.V., a gene therapy company, engages in the development of treatments for patients suffering from genetic and other devastating diseases. Its lead program is Etranacogene dezaparvovec (AMT-061), which is in Phase III HOPE-B pivotal trial for the treatment of hemophilia B. The company also engages in developing AMT-130, a gene therapy th...

Get notified when there are updates to the investment portfolio of Baird Financial Group, Inc., based on Form 13F filings with the SEC.

Stay updated on Baird Financial Group, Inc. with notifications on news.